CAPRICOR THERAPEUTICS, INC. 4
4 · CAPRICOR THERAPEUTICS, INC. · Filed Mar 18, 2016
Insider Transaction Report
Form 4
GERSHELL LELAND
CHIEF FINANCIAL OFFICER
Transactions
- Purchase
Warrants (Right to Buy)
2016-03-16$0.13/sh+1,050$131→ 1,050 totalExercise: $4.50From: 2016-09-17Exp: 2019-03-16→ Common Stock (1,050 underlying) - Purchase
Common Stock
2016-03-16$2.40/sh+2,100$5,040→ 2,100 total
Footnotes (1)
- [F1]The Reporting Person entered into a Subscription Agreement with Capricor Therapeutics, Inc. (the "Issuer") pursuant to which the Reporting Person, on March 16, 2016, purchased (i) 2,100 shares of the Issuer's common stock at a purchase price of $2.40 per share, and (ii) warrants to purchase up to an aggregate of 1,050 shares of the Issuer's common stock at a purchase price of $0.125 per share issuable upon exercise of the warrants, for an aggregate purchase price of approximately $5,171.